LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. As of November 15, 2022, LogicBio Therapeutics, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc..

LogicBio Therapeutics, Inc.

Z Tech Services, Inc. provides representation and consultation for the electronics production industry.

Z Tech Services, Inc.

Wish is an online shopping platform that allows consumers to purchase various products at discounted prices. It offers a wide range of goods from different categories and suppliers.

Metric
Company Name	LogicBio Therapeutics, Inc.	Z Tech Services, Inc.
Symbol	LOGC
MSH ID	COM:WISH	COM:ZTECHSERVICES
Market	STOCKS	PRIVATE
Sector	Healthcare	Commercial & Professional Services
Industry	Biotechnology	Electronics Manufacturing
Country	US	US
Stage
Employee Count	452
Website	logicbio.com	ztechservices.com
LinkedIn		z-tech-services-llc
Founders

Metric
Market Cap	140.10M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	287M
Revenue (LTM)
Revenue (NTM)
Gross Profit	59M
EBITDA	-324M
Operating Income	-328M
Net Income	-317M
EPS	-13.36
Diluted EPS	-13.36
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	1
Operating Profit Margin	-1.27
EBITDA Margin	-1.13
Net Profit Margin	-1.26
Return on Equity	-0.87
Return on Assets	-0.64
Return on Capital Employed	-0.90

COM:WISH

Wish

Last Close

6.96

22/11 21:00

Market Cap

140.10M

Beta: -

Volume Today

259.85K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-3.78
P/B Ratio	4.34
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	25.65
EV Multiple	-1.05

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle	12.86
Cash Conversion Cycle
Asset Turnover	0.98

Metric
Operating Cash Flow	-341M
Free Cash Flow	-344M
Cash Flow to Debt
Operating Cash Flow/Sales	-1.43
Free Cash Flow Yield

Metric
Cash & Equivalents	238M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization	0.30
Debt to Assets	0.26
Current Ratio	1.99
Quick Ratio	31.80

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.38
R&D to Revenue	1.78
SG&A to Revenue	1.18